Otizmde Tedavinin Genel İlkeleri

Rogers SJ, Vismara LA. Evidence-Based Comprehensive Treatments for Early Autism. Journal of Clinical Child and Adolescent Psychology. 2008;37(1): 8-38. doi: 10.1080/15374410701817808.

Mukaddes NM. Otizm Spektrum Bozuklukları. İstanbul: Nobel Tıp Kitabevleri; 2017.

Bilgiç A. Otizm Spektrum Bozuklukları. Bebek Ruh Sağlığı (0-4 Yaş) Temel Kitabı içinde. Ankara: Akademisyen Kitabevi; 2020. p. 459-480.

Smith T. Applied Behavior Analysis and Early Intensive Behavioral Intervention. Autism Spectrum Disorders. 2011; p:1036-1055. doi: 10.1093/med/9780195371826.003.0066.

Smith T, Eikeseth S. O. Ivar lovaas: pioneer of applied behavior analysis and intervention for children with autism. Journal of Autism and Developmental Disorders. 2011;41(3):375-378. doi: 10.1007/s10803-010-1162-0.

Bellini S, Akullian J. A Meta-Analysis of Video Modeling and Video Self-Modeling Interventions for Children and Adolescents with Autism Spectrum Disorders. Exceptional Children. 2007;73(3): 264-287. doi: 10.1177/001440290707300301.

Boyd BA, McDonough SG, Rupp B, et al. Effects of a family-implemented treatment on the repetitive behaviors of children with autism. Journal of Autism and Developmental Disorders. 2011;41(10): 1330-1341. doi: 10.1007/s10803-010-1156-y.

Strain P, Schwartz I. ABA and the Development of Meaningful Social Relations for Young Children with Autism. Focus on Autism and Other Developmental Disabilities. 2001;16(2): 120-128. doi: 10.1177/108835760101600208.

Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010;125(1): e17-23. doi: 10.1542/peds.2009-0958.

Lovaas OI. Behavioral treatment and normal educational and intellectual functioning in young autistic children. Journal of Consulting and Clinical Psychology. 1987;55(1): 3-9. doi: 10.1037//0022-006x.55.1.3.

Lovaas OI. The development of a treatment-research project for developmentally disabled and autistic children. Journal of Applied Behavior Analysis. 1993;26(4): 617-630. doi: 10.1901/jaba.1993.26-617.

Eldevik S, Hastings RP, Hughes JC, et al. Meta-analysis of Early Intensive Behavioral Intervention for children with autism. Journal of Clinical Child and Adolescent Psychology. 2009;38(3): 439-450. doi: 10.1080/15374410902851739.

Magiati I, Charman T, Howlin P. A two-year prospective follow-up study of community-based early intensive behavioural intervention and specialist nursery provision for children with autism spectrum disorders. Journal of Child Psychology and Psychiatry. 2007;48(8): 803-812. doi: 10.1111/j.1469-7610.2007.01756.x.

Mohammadzaheri F, Koegel LK, Rezaee M, et al. A randomized clinical trial comparison between pivotal response treatment (PRT) and structured applied behavior analysis (ABA) intervention for children with autism. Journal of Autism and Developmental Disorders. 2014;44(11): 2769-2777. doi: 10.1007/s10803-014-2137-3.

Schreibman L, Dawson G, Stahmer AC, et al. Naturalistic Developmental Behavioral Interventions: Empirically Validated Treatments for Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. 2015;45(8): 2411-2428. doi: 10.1007/s10803-015-2407-8.

Kasari C, Freeman S, Paparella T. Joint attention and symbolic play in young children with autism: a randomized controlled intervention study. Journal of Child Psychology and Psychiatry. 2006;47(6): 611-620. doi: 10.1111/j.1469-7610.2005.01567.x.

Koegel RL, Openden D, Fredeen RM, et al. The Basics of Pivotal Response Treatment. In: Koegel RL, Koegel LK (eds.) Pivotal Response Treatments for Autism: Communication, Social, & Academic Development. Baltimore, MD: Brookes; 2006. p. 3–30.

Koegel LK, Koegel RL, Shoshan Y, et al. Pivotal response intervention II: Preliminary long-term outcome data. The Journal of the Association for Persons with Severe Handicaps. 1999;24(3): 186-198. doi: 10.2511/rpsd.24.3.186.

Ventola P, Friedman HE, Anderson LC, et al. Improvements in social and adaptive functioning following short-duration PRT program: a clinical replication. Journal of Autism and Developmental Disorders. 2014;44(11): 2862-2870. doi: 10.1007/s10803-014-2145-3.

Sherer MR, Schreibman L. Individual behavioral profiles and predictors of treatment effectiveness for children with autism. Journal of Consulting and Clinical Psychology. 2005;73(3): 525-538. doi: 10.1037/0022-006X.73.3.525.

Hardan AY, Gengoux GW, Berquist KL, et al. A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism. Journal of Child Psychology and Psychiatry. 2015;56(8): 884-892. doi: 10.1111/jcpp.12354.

Mohammadzaheri F, Koegel LK, Rezaee M, et al. A randomized clinical trial comparison between pivotal response treatment (PRT) and structured applied behavior analysis (ABA) intervention for children with autism. Journal of Autism and Developmental Disorders. 2014;44(11): 2769-2777. doi: 10.1007/s10803-014-2137-3.

Koegel RL, Bimbela A, Schreibman L. Collateral effects of parent training on family interactions. Journal of Autism and Developmental Disorders. 1996;26(3): 347-359. doi: 10.1007/BF02172479.

Greenspan SI, Wieder S. Relationship-Based Early Intervention Approach to Autistic Spectrum Disorders: The Developmental, Individual Difference, Relationship-Based Model (The DIR Model). In: Amaral D, Geschwind D, Dawson G, editors. Autism Spectrum Disorders. Oxford: Oxford University Press; 2011. p. 1068–1080.

Paul R, Sutherland D. Enhancing early language in children with autism spectrum disorders. In: Volkmar FR, Paul R, Klin A, Cohen DJ, editors. Handbook of autism and pervasive developmental disorders. 3rd ed. New York: Wiley; 2005. p. 946–977.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington (DC): American Psychiatric Association Publishing; 2013. p. 947.

Politte LC, Henry CA, McDougle CJ. Psychopharmacological interventions in autism spectrum disorder. Harvard Review of Psychiatry. 2014;22(2): 76-92. doi: 10.1097/HRP.0000000000000030.

Spencer D, Marshall J, Post B, et al. Psychotropic medication use and polypharmacy in children with autism spectrum disorders. Pediatrics. 2013;132(5): 833-840. doi: 10.1542/peds.2012-3774.

Esbensen AJ, Greenberg JS, Seltzer MM, et al. A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders. 2009;39(9): 1339-1349. doi: 10.1007/s10803-009-0750-3.

Ames CS, White SJ. Are ADHD traits dissociable from the autistic profile? Links between cognition and behaviour. Journal of Autism and Developmental Disorders. 2011;41(3): 357-363. doi: 10.1007/s10803-010-1049-0.

Kılınçaslan A, Mukaddes NM, Küçükyazıcı GS, et al. Asperger Bozukluğu Olgularında Yürütücü İşlevler ve Dikkatin Değerlendirilmesi. Türk Psikiyatri Dergisi. 2010;21(4): 289-299.

Research Units on Pediatric Psychopharmacology Autism Network. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62(11): 1266-1274. doi: 10.1001/archpsyc.62.11.1266.

Aman MG, Farmer CA, Hollway J, et al. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 2008;17(4): 713-738. doi: 10.1016/j.chc.2008.06.009.

Harfterkamp M, Buitelaar JK, Minderaa RB, et al. Long-term treatment with atomoxetine for attention-deficit/hyperactivity disorder symptoms in children and adolescents with autism spectrum disorder: an open-label extension study. Journal of Child and Adolescent Psychopharmacology. 2013;23(3): 194-199. doi: 10.1089/cap.2012.0012.

Propper L. Managing disruptive behaviour in autism-spectrum disorder with guanfacine. Journal of Psychiatry & Neuroscience. 2018;43(5): 359-360. doi: 10.1503/jpn.180039.

Reiersen AM, Handen B. Commentary on ‘Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)’. Evidence-Based Child Health: A Cochrane Review Journal. 2011;6(4): 1082-1085. doi: 10.1002/ebch.786.

Reiersen AM, Todd RD. Co-occurrence of ADHD and autism spectrum disorders: phenomenology and treatment. Expert Review of Neurotherapeutics. 2008;8(4): 657-669. doi: 10.1586/14737175.8.4.657.

Gupta N, Gupta M, Gandhi R. Buspirone in Autism Spectrum Disorder: A Systematic Review. Cureus. 2023;15(5): e39304. doi: 10.7759/cureus.39304.

Hollander E, Soorya L, Chaplin W, et al. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. American Journal of Psychiatry. 2012;169(3): 292-299. doi: 10.1176/appi.ajp.2011.10050764.

Martin A, Koenig K, Anderson GM, et al. Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. Journal of Autism and Developmental Disorders. 2003;33(1): 77-85. oi: 10.1023/a:1022234605695.

Giannotti F, Cortesi F, Cerquiglini A, et al. An open-label study of controlled-release melatonin in treatment of sleep disorders in children with autism. Journal of Autism and Developmental Disorders. 2006;36(6): 741-752. doi: 10.1007/s10803-006-0116-z.

Huffman LC, Sutcliffe TL, Tanner ISD, et al. Management of symptoms in children with autism spectrum disorders: a comprehensive review of pharmacologic and complementary-alternative medicine treatments. Journal of Developmental & Behavioral Pediatrics. 2011;32(1): 56-68. doi: 10.1097/DBP.0b013e3182040acf.

Lecavalier L. Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. Journal of Autism and Developmental Disorders.2006;36(8): 1101-1114. doi: 10.1007/s10803-006-0147-5.

Canitano R, Scandurra V. Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatric Disease and Treatment. 2008;4(4): 723-730. doi: 10.2147/ndt.s1450.

Hollander E, Wasserman S, Swanson EN, et al. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology. 2006;16(5): 541-548. doi: 10.1089/cap.2006.16.541.

Doyle CA, McDougle CJ. Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues in Clinical Neuroscience. 2012;14(3): 263-279. doi: 10.31887/DCNS.2012.14.3/cdoyle.

Locascio JJ, Malone RP, et al. Factors related to haloperidol response and dyskinesias in autistic children. Psychopharmacology Bulletin. 1991;27(2): 119-126.

McDougle CJ, Stigler KA, Posey DJ. Treatment of aggression in children and adolescents with autism and conduct disorder. Journal of Clinical Psychiatry. 2003;64(4): 16-25.

Marcus CL. Pediatric sleep medicine comes into its own. Pediatrics. 2004;113(5):1393-4. doi:10.1542/peds.113.5.1393.

Salomone E, Charman T, McConachie H, et al. Prevalence and correlates of use of complementary and alternative medicine in children with autism spectrum disorder in Europe. European Journal of Pediatrics. 2015;174(10): 1277-1285. doi: 10.1007/s00431-015-2531-7.

Doenyas C. Mikrobiyota ve Otizm. Türkiye Sağlık Bilim Ve Araştırmaları Dergisi. 2019;1(2): 43-48.

Kaynar AN, Yılmaz HÖ. Otizm Spektrum Bozukluğu Olan Çocuklarda Beslenme Durumunun Belirlenmesi. Gümüşhane Üniversitesi Sağlık Bilim Dergisi. 2020;9(2): 151-162. doi: 10.37989/gumussagbil.544033.

Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 2008;17(4): 803-820, ix. doi: 10.1016/j.chc.2008.06.004.

Gao Y, Sheng C, Xie RH, et al. New Perspective on Impact of Folic Acid Supplementation during Pregnancy on Neurodevelopment/Autism in the Offspring Children - A Systematic Review. PloS One. 2016;11(11): e0165626. doi: 10.1371/journal.pone.0165626.

Bertoglio K, Jill James S, Deprey L, et al. Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. Journal of Alternative and Complementary Medicine. 2010;16(5): 555-560. doi: 10.1089/acm.2009.0177.

Uçar K, Samur FG. Otizmin Tedavisinde Güncel Beslenme Tedavisi Yaklaşımları. Beslenme ve Diyet Dergisi. 2017;45(1): 53-60.

Evangeliou A, Vlachonikolis I, Mihailidou H, et al. Application of a ketogenic diet in children with autistic behavior: pilot study. Journal of Child Neurology. 2003;18(2): 113-118. doi: 10.1177/08830738030180020501.

Cohen SA, Gold BD, Oliva S, et al. Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. Journal of Pediatric Gastroenterology and Nutrition. 2014;59(4): 516-521. doi: 10.1097/MPG.0000000000000449.

Amminger GP, Berger GE, Schäfer MR, et al. Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biological Psychiatry. 2007;61(4): 551-553. doi: 10.1016/j.biopsych.2006.05.007.

Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 2008;17(4):803-820. doi: 10.1016/j.chc.2008.06.004.

Sampanthavivat M, Singkhwa W, Chaiyakul T, et al. Hyperbaric oxygen in the treatment of childhood autism: a randomised controlled trial. Diving and Hyperbaric Medicine. 2012;42(3): 128-133.

Holtmann M, Steiner S, Hohmann S, et al. Neurofeedback in autism spectrum disorders. Developmental Medicine & Child Neurology. 2011;53(11): 986-993. doi: 10.1111/j.1469-8749.2011.04043.x.